“Efficacy, Safety and tolerability of the once-daily 10 cm² rivastigmine patch formulation in the patients with dementia (with probable Alzheimer’s disease)” (2013) Bangladesh Journal of Neuroscience, 29(1), pp. 5–14. doi:10.3329/bjn.v29i1.56165.